Strategic Partnerships Leverage Harrington Discovery Institute’s transatlantic collaborations, including the Oxford-Harrington Rare Disease Centre and the planned Therapeutics Accelerator, to position your company as a partner in rare disease research and development initiatives targeting cross-border programs.

Rare Disease Focus Target their emphasis on translating discoveries into medicines for human health by offering services or technologies that accelerate early discovery, lead optimization, or translational studies in rare diseases, aligning with their mission to advance innovative therapeutics.

Scientific Leadership Engage with their Scientific Symposium ecosystem and Harrington Scholars network to sponsor knowledge exchange, co-host sessions, or provide enabling tools that showcase your capabilities to researchers and donors involved in cutting-edge biomedical innovation.

Materials & Tech Offer platforms or services that support pharmaceutical manufacturing readiness, data management, or regulatory documentation for early-stage programs, aligning with their industry landscape and potential need for scalable, compliant infrastructure.

Funding Alignment Present value propositions that complement their $10–$25 million revenue scale and philanthropic funding model, such as pilot collaborations, grant-compatible technology licenses, or co-funding opportunities for translational studies and accelerator initiatives.